S
Sage Therapeutics (SAGE)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Sage Therapeutics (SAGE)
SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenou... Read more
- USD9.16
- USD9.17
- USD9.10
- USD13.47
- 0.20%
- 47M
- 1.94M
- 2.50M
- 581M
- 4.62
- -24.80%
Stock News
3 hours ago
Was canceling Stephen Colbert’s ‘Late Show’ really about money? The numbers don’t entirely back it up.
MarketWatch
3 hours ago
Why Netflix's beat-and-raise quarter is welcome news for Disney investors
CNBC
4 hours ago
International inbound travel to U.S. shows mixed recovery
CNBC
4 hours ago
Insurers just marked the costliest first half of the year since 2011
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
